IMVT
Immunovant, Inc. · Healthcare
General Counsel Mark S. Levine sold $188K of Immunovant, Inc.
Sold$187,988
$18.51Price
10,156Shares
−4%Stake
What IMVT did after the filing
- The stock from Fri, Jan 27 open, $17.39
- −9.1%
- S&P 500, same days
- −4.5%
Measured over 30 trading days, to the Mar 13 close.
Traded Thu, Jan 26. Filed Fri, Jan 27, 2:20 AM ET, before the open. Returns use the Jan 27 open and the Mar 13 close. Not investment advice.